7慢性丙型肝炎抗病毒治疗专家共识.pdfVIP

() 2009 8 3 3 Chin J ExpClni InfectDis (ElectronicEdition),August2009, Vol 3, o. 3 343 ( pegylated interferon, PegIF )( ribavirin, RBV)( chronic hepatitis C, CHC), 65% ( sustained virological response, SVR) [ 1, 2] , ( responseguided therapy, RGT) () ! ( ) !, , !( !) !CHC, , 1CHC , , ! 1 ∀ M eta # ∃ [ 3] HCV 25~ 30 5% ~ 25% , HCV [4] 10 30%, 1% ~ 3% [ 5] , HCV , HCV , HCV, , ( sustained virological response, SVR) [ 6] 2 HCV R A, CHCCHC 3[ 6, 7] ALT [ 8, 9] ( #), , , 344 () 2009 8 3 3 Chin JExp Clni InfectDis (ElectronicEdition),August2009, Vol 3, o. 3 CHC 4~ 5( ∀ ) [ 1, 2, 6, 7, 10, 11] HCV CHC, , 2/3, , HCV [ 1, 2, 11], PegIF RBV IF RBV PegIF RBV CHC% ( ∀ ), PegIF RBV 5 , 1()HCV R A(HCV R A 6 ∋ 10 IU / m l) 2 CHC ( RVR) 4, HCV R A ( LLD) ( cEVR) 12, HCV R A LLD ( pEVR) 12, HCV R A 2 log IU /ml(/m,l), LLD 10 ( ETVR) HCV R A LLD ( SVR) ETVR, 24HCV R A LLD ( relapse) ETVR, HCV R A ( breakthrough) HCV R A LLD, HCV R A ( nonresponder) 24 , HCV R A : ( rapid virological response, RVR); ( lower lmi it of detection, LLD); ( complete early virologi cal re